[Benefit assessment of bisphosphonates, teriparatide and denosumab for the treatment of postmenopausal osteoporosis]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004285
German
Original Title:
Bisphosphonate, Teriparatid und Denosumab zur Behandlung der postmenopausalen Osteoporose
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a19-10.html
Year Published:
2022
URL for published report:
https://www.iqwig.de/download/a19-10_bisphosphonate-teriparatid-und-denosumab-bei-postmenopausaler-osteoporose_abschlussbericht_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Osteoporosis, Postmenopausal
- Diphosphonates
- Alendronate
- Ibandronic Acid
- Risedronic Acid
- Zoledronic Acid
- Teriparatide
- Denosumab
- Bone Density Conservation Agents
Keywords
- Diphosphonates
- Alendronate
- Ibandronic Acid
- Risedronic Acid
- Zoledronic Acid
- Teriparatide
- Denosumab
- Osteoporosis - Postmenopausal Benefit Assessment
- Systematic Review
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.